Benjamin Thompson
Pulmonary Disease · Lake Charles, LANPI 1710996079
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 343 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by GSK at 27.0% of the total. Reporting peaked in 2019 at $1,911 and has fallen 98.6% since, to $27 in 2025.
Across 343 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$660
- Boehringer Ingelheim$414
- CSL Behring$379
- Sunovion Pharmaceuticals Inc.$341
- Regeneron Healthcare Solutions, Inc.$264
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,82298%
- Education$912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 114 | $1,595 |
| AstraZeneca | 33 | $660 |
| Boehringer Ingelheim | 27 | $414 |
| CSL Behring | 18 | $379 |
| Sunovion Pharmaceuticals Inc. | 31 | $341 |
| Regeneron Healthcare Solutions, Inc. | 8 | $264 |
| Novartis | 11 | $262 |
| Johnson & Johnson | 16 | $223 |
| Philips North America LLC | 14 | $206 |
| Sanofi | 9 | $196 |
| Actelion Pharmaceuticals US, Inc. | 11 | $170 |
| Baxter Healthcare | 5 | $148 |
| Abiomed | 1 | $122 |
| Mylan Specialty L.p. | 6 | $103 |
| Genentech USA, Inc. | 6 | $101 |
| Fisher & Paykel Healthcare Inc | 1 | $95 |
| United Therapeutics Corporation | 5 | $89 |
| Insmed, Inc. | 6 | $84 |
| Grifols USA, LLC | 4 | $80 |
| Sanofi-aventis U.S. LLC | 1 | $75 |
| Intuitive Surgical | 2 | $74 |
| Bayer | 3 | $54 |
| Amgen | 2 | $39 |
| Gilead | 2 | $36 |
| Hologic Sales And Service, LLC | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Merck | 1 | $16 |
| Haemonetics Corporation | 1 | $13 |
| Boston Scientific | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,913 in reported general payments places this provider in the 60th percentile of 189 pulmonary disease providers in Louisiana.
Other pulmonary disease in Lake Charles
- Gary KohlerLake Charles$21K
- Luke WilliamsLake Charles$16K
- Robert BroussardLake Charles$15K
- Clifford CourvilleLake Charles$15K
- Tashfeen MahmoodLake Charles$14K
- Andrea EspinozaHouma$655K
- Joseph LaskyNew Orleans$447K
- Hollis O NealBaton Rouge$418K
- Ramsy AbdelghaniNew Orleans$308K
- Juzar AliNew Orleans$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.